Hey there! Welcome!
Get updated on
stem cell
stem cell
stem cell
Top Picks

calendar
23 Feb, 26
The updated international urticaria guideline describes its definition, classification and recommendations for diagnosing and managing its various subtypes.

calendar
3 Feb, 26
This IDSA guideline outlines evidence‑based empiric and definitive antibiotic selection for complicated UTI, emphasizing severity‑based therapy, resistance risk assessment, patient‑specific factors, and stewardship‑driven narrowing once cultures return.

calendar
20 Feb, 26
dot
link
Br. J. Dermatol.
  • In atopic dermatitis, global comorbidity prevalence was 20.1% asthma, 45.1% rhinitis, 41.4% allergic rhinitis, 30.7% rhinoconjunctivitis, and 10.4% combined asthma–rhinitis.
  • Highest rates occurred in India, Cuba, Finland, Puerto Rico.
  • AD increased odds of asthma (OR 2.73), rhinitis (OR 2.98), allergic rhinitis (OR 2.42), rhinoconjunctivitis (OR 4.21), and combined disease (OR 2.42).

calendar
18 Feb, 26
dot
link
Oral Dis.
  • Systematic review (n=983 cases; 968 oral surgery) assessed bleeding risk in dental interventions with platelet counts <50,000/μL
  • Post-op bleeding occurred in 65 cases (12.9% vs 4.9% for ≥50,000/μL; RR 2.95; p<0.0001), including 1 life-threatening event
  • Low platelets increase bleeding risk but are not absolute contraindication; individualized assessment is essential.

calendar
18 Feb, 26
dot
link
Diabetes Metab Syndr...
  • The umbrella review of 20 systematic reviews (675 studies) found high prevalence of cardiometabolic & renal long-term conditions in T2DM patients
  • Cardiovascular disease pooled prevalence ranged from 13.0% to 46.0% & HF up to 25.0, nephropathy pooled prevalence ranged from 4.2% to 38.0% & CKD 18.2% to 35.5%
  • Rates were higher in males & LMICs, targeted management may address the comorbidities effectively.

calendar
17 Feb, 26
dot
link
Diabetes Metab Syndr...
  • Systematic review/meta-analysis of 15 studies (12 outcomes) on alpha-lipoic acid (ALA) in diabetic polyneuropathy was conducted
  • ALA 600 mg/day improved TSS paresthesia (SMD = −1.04; p<0.00001), numbness (SMD = −0.23; p=0.04) & HPAL (SMD = −1.00; p<0.00001)
  • No effect on HbA1c, NO, sural SNAP, peroneal MNCV
  • ALA is a safe adjunct for symptom relief but its impact on nerve conduction/glycemic control is inconclusive.

In this webcast, the speakers have discussed the FOT Essentials and Basics, Interpretation Secrets and Advanced applications, different adult & pediatric case studies presented during the session and how Oscillometry revolutionized the diagnosis.

GINA 2024
GINA 2024
GINA 2024